Viatris (VTRS) Amortization - Goodwill (2023 - 2025)
Viatris (VTRS) recorded quarterly Amortization - Goodwill of $2.9 billion in Q1 2025, up 815.89% quarter-over-quarter from $321.0 million in Q2 2024.
Viatris (VTRS) Amortization - Goodwill (2023 - 2025) Analysis & Trends
Viatris' Amortization - Goodwill history runs 3 years deep, the most recent figure standing at $2.9 billion for Q1 2025.
- In Q1 2025, Amortization - Goodwill changed N/A year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 815.89% YoY), while the FY2025 annual figure was $2.9 billion, up 814.89% from the prior year.
- Amortization - Goodwill was $2.9 billion for Q1 2025 at Viatris, up from $321.0 million in the prior quarter.
- In the past five years, Amortization - Goodwill ranged from a high of $2.9 billion in Q1 2025 to a low of $321.0 million in Q2 2024.
- Historically, Amortization - Goodwill has averaged $1.3 billion across 3 years, with a median of $580.1 million in 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.94 Bn |
| Jun 30, 2024 | 321.00 Mn |
| Dec 31, 2023 | 580.10 Mn |